A new generation accelerates the path from bench to bedside
Innovations in Neurology and Neurosurgery
Ranked #40 in the nation by U.S. News & World Report.
Innovations in care and research
The Ohio State University’s Neurological Institute is the highest nationally ranked program for neurology and neurosurgery in Columbus with over 200 medical, surgical and research specialists dedicated to the treatment of patients with neurological and psychiatric disorders.
Read more about our latest clinical trials and research innovations taking place every day. Visit the Neurology and Neurosurgery Department websites for additional information.
Young investigators are moving nervous system repair closer to reality
Building bridges across continents: neurology leaders forge global partnerships
The long reach of a dedicated teleneurology team
Partnering with developing countries to improve brain health worldwide
How gene therapy is evolving for spinal muscular atrophy and neuromuscular diseases
Ohio State neurology team attacks headache: Creating and evaluating a new model of care
Featured Stories
New Division of Neurogenetics paves way for expanded personalized medicine through clinical trials, gene targeted therapies
Neurology physician implementing teleneurology services to connect academic medical providers with local physicians
The Department of Neurology launches Division of Health Services Research
Neurology physician committed to educating tomorrow’s multiple sclerosis specialists
Neurology researchers testing novel immune cell’s ability to rescue damaged human nerve cells and induce the nerve fiber regeneration
Neurology researchers receive NIH grant, study what causes loss of motor function as we age
New specialty clinics offer highly personalized care to patients with neurological disorders
Portable MRIs provide lifesaving bedside brain imaging for stroke patients
Brain bank expansion will boost novel neurological research
Recent Department of Neurology expansion includes advances in teleneurology, accessibility, and genetics and aging research
A new approach to gene therapy provides hope to those living with incurable neurologic disorders
Directional and sensing DBS system delivers more personalized treatment for Parkinson’s disease
Certain immune-suppressing therapies reduce vaccine response in subset of multiple sclerosis patients
Novel research explores neurobiological mechanisms driving sarcopenia in aging
New partnership brings SAGE to a digital format
Ohio State establishing national standards for ALS genetic testing, research and patient care
Ohio State researchers identify new biomarkers that differentiate Lewy body dementia from Alzheimer’s and Parkinson’s
Biomarker breakthroughs at Ohio State transform disease diagnosis, predictability and treatment
The Ohio State University Wexner Medical Center pushes boundaries for neurological care
Multiple sclerosis and COVID-19: Experts at The Ohio State University Wexner Medical Center use data to guide care
Creating quantifiable metrics for back pain
Discovery of Pro-Regenerative Neutrophils Could be Breakthrough in Treating Incurable Neurological Diseases
Exploring a Onetime Treatment to Halt Parkinson’s Disease
Promising Clinical Trial Shows Benefit of Neuroprotective Therapy in Patients with ALS
The Past, Present and Future of Gene Therapy for Spinal Muscular Atrophy and Neuromuscular Diseases
New Approaches to Treating Movement Disorders with Deep Brain Stimulation and Other Advanced Treatments
Ohio State Researchers Study How to Use the Immune System to Promote Repair in Individuals with Neurological Disease
Krystof Bankiewicz, MD, PhD, Brings Promising Gene Therapy Research to Ohio State
New Neurology Chair Shares Vision for Growth
New Research Center at Ohio State to Study Neuroinflammation
Ohio State Pioneers Ultrasound Technology for Neurological Disorders
Ohio State Researchers Lead Spinal Cord Injury Center
Ohio State Wexner Medical Center Among Nation's Best in 4 Specialty Areas